Tocopherols and the treatment of colon cancer

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 223-233

  Stone, William L ^a   Krishnan, Koyamangalath ^a   Campbell, Sharon E ^a   Qui, Min ^a   Whaley, Sarah G ^a   Yang, Hongsong ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Colon cancer; Tocopherols; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CELL DNA; COMPLEMENTARY DNA; GAMMA TOCOPHEROL; GUANOSINE TRIPHOSPHATASE; LIPID HYDROPEROXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; RAS PROTEIN; RNA; TROGLITAZONE;

ANIMAL MODEL; APOPTOSIS; CANCER CELL CULTURE; CHEMICAL STRUCTURE; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE CELL; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALIA;

EID: 14944366499     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.022     Document Type: Conference Paper

References (48)

1. NELSON, R.L. et al. 1994. Body iron stores and risk of colonic neoplasia. J. Natl. Cancer Inst. 86: 455-460.
2. NELSON, R.L. 2001. Iron and colorectal cancer risk: human studies. Nutr. Rev. 59: 140-148.
3. BABBS, C.F. 1990. Free radicals and the etiology of colon cancer. Free Radic. Biol. Med. 8: 191-200.
4. SHARMA, R.A. et al. 2001. Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 22: 1557-1560.
5. CHAUDHARY, A.K. et al. 1994. Detection of endogenous malondialdehyde- deoxyguanosine adducts in human liver. Science 265: 1580-1582.
6. BIERI, J.G. & R.P. EVARTS. 1974. Gamma tocopherol: metabolism, biological activity and significance in human vitamin E nutrition. Am. J. Clin. Nutr. 27: 980-986.
7. STONE, W.L. & A.M. PAPAS. 1997. Tocopherols and the etiology of colon cancer. J. Natl. Cancer Inst. 89: 1006-1014.
8. STONE, W.L. et al. 2002. The influence of dietary iron and tocopherols on oxidative stress and ras-p21 levels in the colon. Cancer Detect. Prevent. 26: 78-84.
9. CAMPBELL, S. et al. 2003. Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent. Crit. Rev. Oncol./Hematol. 47: 249-259.
10. KRISHNAN, K. et al. 2003. Cancer chemoprevention drug targets. Curr. Drug Target 4: 45-54.
11. TRAN, K. & A.C. CHAN. 1992. Comparative Uptake of alpha- and gamma-tocopherol by human endothelial cells. Lipids 27: 38-41.
12. JIANG, Q. et al. 2000. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA 97: 11494-11499.
13. GAO, R. et al. 2002. The uptake of tocopherols by RAW 264.7 macrophages. Nutr. J. 1: 2.
14. CAMPBELL, S.E. et al. 2003. Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines. BMC Cancer 3: 25.
15. CLEMENT, M. & J.M. BOURRE. 1997. Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle of vitamin-E-deficient rats. Biochim. Biophys. Acta 1334: 173-181.
16. JIANG, Q. et al. 2001. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 74: 714-722.
17. JIANG, Q. et al. 2002. Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic. Biol. Med. 33: 1534-1542.
18. JIANG, Q. & B.N. AMES. 2003. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 17: 816-822.
19. JACKSON, L. et al. 2003. Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer. Gut 52: 1317-1322.
20. KITAMURA, S. et al. 1999. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn. J. Cancer Res. (Gann) 90: 75-80.
21. MANSEN, A. et al. 1996. Expression of the peroxisome proliferator- activated receptor (PPAR) in the mouse colonic mucosa. Biochem. Biophys. Res. Commun. 222: 844-851.
22. KOHNO, H. et al. 2002. Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Jpn. J. Cancer Res. (Gann) 93: 133-142.
23. TRABER, M.G. & H.J. KAYDEN. 1989. Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 49: 517-526.
24. WOLF, G. 1997. gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr. Rev. 55: 376-378.
25. HOGLEN, N.C. et al. 1997. Reactions of peroxynitrite with gamma-tocopherol. Chem. Res. Toxicol. 10: 401-407.
26. CHRISTEN, S. et al. 1997. gamma-Tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc. Natl. Acad. Sci. USA 94: 3217-3222.
27. SINGH, J., R. HAMID & B.S. REDDY. 1997. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 57: 253-258.
28. SWANSON, J.E. et al. 1999. Urinary excretion of 2,7, 8-trimethyl-2-(beta- carboxy-ethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J. Lipid Res. 40: 665-671.
29. SINGH, J., R. HAMID & B.S. REDDY. 1998. Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis 19: 985-989.
30. MIYAHARA, M. et al. 1991. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer. Dis. Colon Rectum 34: 1097-1102.
31. CASCINU, S. et al. 2000. Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest. 18: 411-416.
32. NAIR, S. et al. 2001. Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls. Am. J. Gastroenterol. 96: 3400-3405.
33. GIACOSA, A. et al. 1997. Vitamins and cancer chemoprevention. Eur. J. Cancer Prevent. 6(Suppl. 1): S47-S54.
34. SLATTERY, M.L. et al. 1998. Vitamin E and colon cancer: is there an association? Nutr. Cancer 30: 201-206.
35. SATIA-ABOUTA, J. et al. 2003. Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiology, Biomarkers, and Prevention: A Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology. 12: 747-754.
36. WU, K. et al. 2002. A prospective study on supplemental vitamin e intake and risk of colon cancer in women and men. Cancer Epidemiology, Biomarkers, and Prevention: A Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology. 11: 1298-1304.
37. BOSTICK, R.M. et al. 1993. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res. 53: 4230-4237.
38. PATTERSON, R.E. et al. 1997. Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control 8: 786-802.
39. CALVIELLO, G. et al. 2003. gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. Carcinogenesis 24: 427-433.
40. SJOHOLM, A., P.O. BERGGREN & R.V. COONEY. 2000. gamma-tocopherol partially protects insulin-secreting cells against functional inhibition by nitric oxide. Biochem. Biophys. Res. Commun. 277: 334-340.
41. COONEY, R.V. et al. 1995. Products of gamma-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Radic. Biol. Med. 19: 259-269.
42. BERTRAM, J.S. et al. 1991. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 12: 671-678.
43. COONEY, R.V., P.D. Ross & G.L. BARTOLINI. 1986. N-Nitrosation and N-nitration of morpholine by nitrogen dioxide: inhibition by ascorbate, glutathione and alpha-tocopherol. Cancer Lett. 32: 83-90.
44. WILLIAMSON, K.S. et al. 2002. The nitration product 5-nitro-gamma- tocopherol is increased in the Alzheimer brain. Nitric Oxide 6: 221-227.
45. COONEY, R.V. et al. 1993. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc. Natl. Acad. Sci. USA 90: 1771-1775.
46. NAIR, P.P. et al. 1996. Uptake and distribution of carotenoids, retinol, and tocopherols in human colonic epithelial cells in vivo. Cancer Epidemiology, Biomarkers, and Prevention: A Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology. 5: 913-916.
47. SATO, H. et al. 2000. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists. Br. J. Cancer 83: 1394-1400.
48. SARRAF, P. et al. 1999. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol. Cell 3: 799-804.